Compare Endeavour Silver Corp (EXK) vs GE HealthCare Technologies Inc. Common Stock (GEHC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Endeavour Silver Corp vs GE HealthCare Technologies Inc. Common Stock — how do they compare? Endeavour Silver Corp trades at $8.03 (market cap $2.32B), while GE HealthCare Technologies Inc. Common Stock trades at $68.6 (market cap $30.93B). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 13.3× Endeavour Silver Corp's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while Endeavour Silver Corp pays none. Which is the better fit depends on your goals.
| EXK | GEHC | |
|---|---|---|
Market Cap | $2.32B | $30.93B |
Volume | 8,976,489 | 5,033,451 |
Sector | Basic Materials | Health |
52-Week High | $14.12 | $88.16 |
52-Week Low | $7.07 | $59.48 |
Typical Hold Time | 26 Days | — |
Enterprise Value | $2.32B | $39.39B |
Dividend Yield | — | 0.23% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Endeavour Silver (EXK) trades at $8.24, down 3.51% on the day, amid a bearish technical signal with moving averages indicating selling pressure. The company reported a net loss of $119.1 million in 2025 but improved to a net profit of $66 million in 2026, driven by revenue growth from $468 million to $737 million. Recent news highlights operational progress at the Terronera mine and a temporary mechanical issue at Guanacevi, while analyst consensus remains strongly positive with 11 buy ratings.
The outlook for EXK hinges on successful execution of mine expansions and favorable silver prices, offering growth potential, but risks include operational disruptions, commodity price volatility, and high valuation multiples. Investors should weigh the strong analyst support against near-term profitability challenges and market sentiment.
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Endeavour Silver Corp
Endeavour Silver is a mid-tier precious metals mining company. It operates silver-gold mines in Mexico and is focused on growing its production and reserves through exploration and the development of new mining projects.
Read more on EXK →About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →
